FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to a drug for gastroduodenal diseases caused by Helicobacter pylori, and to a method of treating these diseases by inhibiting apoptosis in gastric epitheliocytes, administering the drug containing an amount of a peptide of formula H-Glu-Asp-Gly-OH effective with respect to Helicobacter pylori. The invention also concerns a pharmaceutical composition and applying it.
EFFECT: group of inventions provides producing a new group of the preparations containing biologically active compounds on the basis of peptides, exhibiting specific activity with respect to Helicobacter pylori.
9 cl, 4 ex, 1 tbl, 17 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| PEA PROTEIN PEPTIDES WITH ANTI-Helicobacter pylori ACTIVITY | 2011 |
|
RU2558304C2 |
| PEPTIDE POSSESSING STRESS-PROTECTING EFFECT, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD FOR ITS USING | 2006 |
|
RU2304444C1 |
| PHARMACEUTICAL COMPOSITION ON BASIS OF PEPTIDE POSSESSING ANTITUMORAL ACTION | 2007 |
|
RU2362579C1 |
| MONOCLONAL ANTIBODY SUPPRESSING THE IMMUNOSUPPRESSIVE FUNCTIONS OF PATHOGENS, ANTIGEN-BINDING FRAGMENT OF THE SPECIFIED ANTIBODY AND HYBRIDOMAS PRODUCING THE SPECIFIED ANTIBODY | 2017 |
|
RU2751918C2 |
| MODIFIED MITOCHONDRIA AND THEIR USE | 2019 |
|
RU2811467C2 |
| PEPTIDE POSSESSING IMMUNOGEROPROTECTIVE EFFECT, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD FOR ITS USING | 2006 |
|
RU2301074C1 |
| PEPTIDE STIMULATING REGENERATION OF CENTRAL NERVOUS SYSTEM NEURONS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD FOR ITS USING | 2006 |
|
RU2301678C1 |
| METHOD FOR PREVENTION OF STOMACH ULCERS IN RENAL OPERATIONS | 2016 |
|
RU2711207C2 |
| PEPTIDE NORMALIZING METABOLISM IN OSSEOUS AND CARTILAGE TISSUE, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD FOR ITS USING | 2006 |
|
RU2299741C1 |
| PEPTIDE GLP-2 AGONISTS | 2010 |
|
RU2551977C2 |
